In regards to the stock of this high-quality pharmaceutical distributor, the author of today’s article declares that it “is not just cheap – it’s incredibly cheap.” But what about concerns the market currently has about this stock – namely Amazon’s entrance into the drug distribution space and White House rhetoric on drug prices? The author lays out how, under even the worst-case scenario for this company, it’s a “heads we win, tails we get less, but we still win” scenario for investors. For more, CLICK HERE.
Tech stocks and large-cap stocks such as Amazon and Netflix have led the bull market higher, but the author of today’s article cautions that, with these stocks currently making up 25% of the S&P 500, there may be too high a concentration of high tech stocks – and this could spell trouble for passive investors with money in index funds tracking the S&P 500. For more – including how investors in this position can go about reducing their risk (via either an active or passive approach) – CLICK HERE.
They don’t get the headlines that Facebook, Amazon, Netflix and Alphabet generate, but the five technology companies highlighted in today’s article are currently disrupting a variety of industries – “transforming how we interact with our devices, manage inventory, generate sales leads, purchase advertising, and play video games…” Moreover, each of these five companies has only just begun in the disruption of their respective areas – presenting potential opportunities for investors. To read more, CLICK HERE.
Looking for stocks that will do better for you than Amazon and Netflix? Today’s article highlights one obscure S&P subsector that has outperformed FANG stocks so far this year, up 41% compared to FANG’s less than 36% gain: the life sciences subsector. Why is life sciences viewed as a “dream growth sector” right now, what are some top life sciences stocks to consider (including the sector’s version of FANG — TAMP), and how can you invest in this sector without a whole lot of knowledge about its individual stocks? CLICK HERE.
While Amazon may be a great success story, the author of today’s article acknowledges a depressing subplot – “Amazon’s ruthless destruction of brick-and-mortar retailers” – and seeks to determine whether the retail sector is still worthy of a chunk of the asset allocation in investment portfolios. The answer may be yes – as long as investors “Amazon-proof” these investments. What retail sub-sectors may be the most Amazon-proof – and what Amazon-proof retailer does the author single out as “one of the relatively few attractive possibilities in the retail sector”? CLICK HERE to find out.
Amazon may be a growth machine, but it isn’t the only one – and it isn’t even the growthiest of growth machines! In fact, today’s article notes that “there are several other companies with even better sales growth, better earnings growth or both” – and it proceeds to highlight nine of them. To find out what these nine stocks experiencing Amazon-beating “breakneck growth” are – a mix of familiar names (e.g. Yelp) and lesser-known plays (e.g. Chinese Amazon copycat JD.com) – CLICK HERE.
Well-known Wall Street analyst Tom Lee is advising investors to forget about FANG stocks (Facebook, Amazon, Netflix and Google) and instead buy CRAP stocks (Computers, Resources, American banks and Phone carriers). And given that Lee was one of the few market analysts to accurately call last year’s bull market, the author of today’s article sees his “Buy CRAP” thesis as being worthy of examination. So, how has the CRAP thesis played out so far this year and, accordingly, does the author believe that investors should in fact “loosen their FANGs and embrace the CRAP”? CLICK HERE to find out.